Contralateral nodal failures in oropharyngeal cancers after TORS and unilateral neck management: a retrospective study

Abstract Background Report the incidence of contralateral nodal failure rates in well-lateralized oropharyngeal carcinoma treated with upfront surgery and unilateral neck management. Methods Lateralized oropharyngeal carcinomas treated with upfront surgery using transoral robotic surgery (TORS) and...

Full description

Saved in:
Bibliographic Details
Main Authors: Axel Sahovaler, John J. W. Lee, Wei Xu, Susie Su, Ali Hosni, Andrew Bayley, David P. Goldstein, John R. de Almeida
Format: Article
Language:English
Published: SAGE Publishing 2021-12-01
Series:Journal of Otolaryngology - Head and Neck Surgery
Subjects:
Online Access:https://doi.org/10.1186/s40463-021-00551-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832544156752281600
author Axel Sahovaler
John J. W. Lee
Wei Xu
Susie Su
Ali Hosni
Andrew Bayley
David P. Goldstein
John R. de Almeida
author_facet Axel Sahovaler
John J. W. Lee
Wei Xu
Susie Su
Ali Hosni
Andrew Bayley
David P. Goldstein
John R. de Almeida
author_sort Axel Sahovaler
collection DOAJ
description Abstract Background Report the incidence of contralateral nodal failure rates in well-lateralized oropharyngeal carcinoma treated with upfront surgery and unilateral neck management. Methods Lateralized oropharyngeal carcinomas treated with upfront surgery using transoral robotic surgery (TORS) and unilateral neck management (unilateral neck dissection ± unilateral radiation treatment) were identified. Primary endpoint was contralateral regional control (CRC). Secondary endpoints were local control (LC), and overall survival (OS). Results Thirty-two patients were included. Pathologic T categories included 66% pT1, 31% pT2 and 3% pT3. Nodal diseases comprised 41% N0 and 47% N1 (AJCC 8th). Twenty-three (72%) patients had HPV related tumors. 3-years CRC, LC and OS were 100%, 96% (89–100) and 96% (CI 89–100). One patient developed a second primary with contralateral nodal disease. Only one patient died from another primary cancer. Conclusion In selected patients with lateralized oropharyngeal cancer, treatment with TORS and ipsilateral management of the neck may be oncologically safe without significant risk of contralateral failure. Level of evidence: Level 2. Graphical abstract
format Article
id doaj-art-c91498bb15a04539a7379186be448b46
institution Kabale University
issn 1916-0216
language English
publishDate 2021-12-01
publisher SAGE Publishing
record_format Article
series Journal of Otolaryngology - Head and Neck Surgery
spelling doaj-art-c91498bb15a04539a7379186be448b462025-02-03T10:54:13ZengSAGE PublishingJournal of Otolaryngology - Head and Neck Surgery1916-02162021-12-015011810.1186/s40463-021-00551-9Contralateral nodal failures in oropharyngeal cancers after TORS and unilateral neck management: a retrospective studyAxel Sahovaler0John J. W. Lee1Wei Xu2Susie Su3Ali Hosni4Andrew Bayley5David P. Goldstein6John R. de Almeida7Department of Otolaryngology Head and Neck Surgery, University of TorontoDepartment of Otolaryngology Head and Neck Surgery, University of TorontoDepartment of Biostatistics, University of TorontoDepartment of Biostatistics, University of TorontoDepartment of Radiation Oncology, University of TorontoDepartment of Radiation Oncology, University of TorontoDepartment of Otolaryngology Head and Neck Surgery, University of TorontoDepartment of Otolaryngology Head and Neck Surgery, University of TorontoAbstract Background Report the incidence of contralateral nodal failure rates in well-lateralized oropharyngeal carcinoma treated with upfront surgery and unilateral neck management. Methods Lateralized oropharyngeal carcinomas treated with upfront surgery using transoral robotic surgery (TORS) and unilateral neck management (unilateral neck dissection ± unilateral radiation treatment) were identified. Primary endpoint was contralateral regional control (CRC). Secondary endpoints were local control (LC), and overall survival (OS). Results Thirty-two patients were included. Pathologic T categories included 66% pT1, 31% pT2 and 3% pT3. Nodal diseases comprised 41% N0 and 47% N1 (AJCC 8th). Twenty-three (72%) patients had HPV related tumors. 3-years CRC, LC and OS were 100%, 96% (89–100) and 96% (CI 89–100). One patient developed a second primary with contralateral nodal disease. Only one patient died from another primary cancer. Conclusion In selected patients with lateralized oropharyngeal cancer, treatment with TORS and ipsilateral management of the neck may be oncologically safe without significant risk of contralateral failure. Level of evidence: Level 2. Graphical abstracthttps://doi.org/10.1186/s40463-021-00551-9TORSContralateral nodal failureOropharyngeal cancer
spellingShingle Axel Sahovaler
John J. W. Lee
Wei Xu
Susie Su
Ali Hosni
Andrew Bayley
David P. Goldstein
John R. de Almeida
Contralateral nodal failures in oropharyngeal cancers after TORS and unilateral neck management: a retrospective study
Journal of Otolaryngology - Head and Neck Surgery
TORS
Contralateral nodal failure
Oropharyngeal cancer
title Contralateral nodal failures in oropharyngeal cancers after TORS and unilateral neck management: a retrospective study
title_full Contralateral nodal failures in oropharyngeal cancers after TORS and unilateral neck management: a retrospective study
title_fullStr Contralateral nodal failures in oropharyngeal cancers after TORS and unilateral neck management: a retrospective study
title_full_unstemmed Contralateral nodal failures in oropharyngeal cancers after TORS and unilateral neck management: a retrospective study
title_short Contralateral nodal failures in oropharyngeal cancers after TORS and unilateral neck management: a retrospective study
title_sort contralateral nodal failures in oropharyngeal cancers after tors and unilateral neck management a retrospective study
topic TORS
Contralateral nodal failure
Oropharyngeal cancer
url https://doi.org/10.1186/s40463-021-00551-9
work_keys_str_mv AT axelsahovaler contralateralnodalfailuresinoropharyngealcancersaftertorsandunilateralneckmanagementaretrospectivestudy
AT johnjwlee contralateralnodalfailuresinoropharyngealcancersaftertorsandunilateralneckmanagementaretrospectivestudy
AT weixu contralateralnodalfailuresinoropharyngealcancersaftertorsandunilateralneckmanagementaretrospectivestudy
AT susiesu contralateralnodalfailuresinoropharyngealcancersaftertorsandunilateralneckmanagementaretrospectivestudy
AT alihosni contralateralnodalfailuresinoropharyngealcancersaftertorsandunilateralneckmanagementaretrospectivestudy
AT andrewbayley contralateralnodalfailuresinoropharyngealcancersaftertorsandunilateralneckmanagementaretrospectivestudy
AT davidpgoldstein contralateralnodalfailuresinoropharyngealcancersaftertorsandunilateralneckmanagementaretrospectivestudy
AT johnrdealmeida contralateralnodalfailuresinoropharyngealcancersaftertorsandunilateralneckmanagementaretrospectivestudy